YTHDF1 and breast carcinoma: Our data showed that YTHDF1 knockdown distinctly lowered the expression of Axin2, c-myc, β-catenin, and cyclin D1 in MCF-7 cells, confirming that YTHDF1 participated in the activation of WNT pathway in breast cancer (Figures 4E–H).